Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers

被引：18
|
作者：
Pravica, Vera [1 ]
Popadic, Dusan [1 ]
Savic, Emina [1 ]
Markovic, Milos [1 ]
Drulovic, Jelena [2 ]
Mostarica-Stojkovic, Marija [1 ]
机构：
[1] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade 11000, Serbia
[2] Univ Belgrade, Sch Med, Inst Neurol CCS, Belgrade, Serbia
来源：
IMMUNOLOGIC RESEARCH | 2012年 / 52卷 / 1-2期
关键词：
Multiple sclerosis; Genetic polymorphism; Biomarkers; Interferon beta; Pharmacogenomics; Ethnic variations; INTERFERON-BETA THERAPY; GENOME-WIDE ASSOCIATION; MESSENGER-RNA EXPRESSION; ALPHA PROMOTER POLYMORPHISMS; TNF-ALPHA; T-CELLS; CONFER SUSCEPTIBILITY; GENE POLYMORPHISM; NEUTRALIZING ANTIBODIES; INTERLEUKIN-7; RECEPTOR;
D O I：
10.1007/s12026-012-8273-y
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Multiple sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative disease of the central nervous system characterized by unpredictable and variable clinical course. Etiology of MS involves both genetic and environmental factors. New technologies identified genetic polymorphisms associated with MS susceptibility among which immunologically relevant genes are significantly overrepresented. Although individual genes contribute only a small part to MS susceptibility, they might be used as biomarkers, thus helping to identify accurate diagnosis, predict clinical disease course and response to therapy. This review focuses on recent progress in research on MS genetics with special emphasis on the possibility to use single nucleotide polymorphism of candidate genes as biomarkers of susceptibility to disease and response to therapy.
引用
收藏
页码：42 / 52
页数：11
相关论文
共 50 条
  • [21] Multiple sclerosis: Disease biomarkers as indicated by pathophysiology
    Berger, Thomas
    Reindl, Markus
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 259 (1-2) : 21 - 26
  • [22] Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms
    Fransen, Nina L.
    Crusius, Jakob B. A.
    Smolders, Joost
    Mizee, Mark R.
    van Eden, Corbert G.
    Luchetti, Sabina
    Remmerswaal, Ester B. M.
    Hamann, Jorg
    Mason, Matthew R. J.
    Huitinga, Inge
    BRAIN PATHOLOGY, 2020, 30 (01) : 106 - 119
  • [23] Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?
    Fontaine, B.
    REVUE NEUROLOGIQUE, 2012, 168 (11) : 833 - 835
  • [24] A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients
    Martire, Serena
    Navone, Nicole D.
    Montarolo, Francesca
    Perga, Simona
    Bertolotto, Antonio
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 292 : 34 - 39
  • [25] Pharmacogenomics of multiple sclerosis: Association of immune response gene polymorphisms with copaxone treatment efficacy
    E. Yu. Tsareva
    O. G. Kulakova
    O. Yu. Makarycheva
    A. N. Boyko
    S. G. Shchur
    N. Yu. Lashch
    N. F. Popova
    E. I. Gusev
    V. V. Bashinskaya
    D. V. Lvov
    A. V. Favorov
    M. F. Ochs
    O. O. Favorova
    Molecular Biology, 2011, 45 : 886 - 893
  • [26] Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severity
    Takagi, Kae
    Kawamoto, Manabu
    Higuchi, Tomoaki
    Tochimoto, Akiko
    Harigai, Masayoshi
    Kawaguchi, Yasushi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (05) : 674 - 680
  • [27] Pharmacogenomics of multiple sclerosis: Association of immune response gene polymorphisms with copaxone treatment efficacy
    Tsareva, E. Yu.
    Kulakova, O. G.
    Makarycheva, O. Yu.
    Boyko, A. N.
    Shchur, S. G.
    Lashch, N. Yu.
    Popova, N. F.
    Gusev, E. I.
    Bashinskaya, V. V.
    Lvov, D. V.
    Favorov, A. V.
    Ochs, M. F.
    Favorova, O. O.
    MOLECULAR BIOLOGY, 2011, 45 (06) : 886 - 893
  • [28] Are single nucleotide polymorphisms underutilized for guiding treatment of inflammatory bowel disease?
    van Der Werf, Jildou
    Fleming, Nicholas Ian
    IMMUNOLOGY AND CELL BIOLOGY, 2025,
  • [29] The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation
    Strange, Richard C.
    Ramachandran, Sudarshan
    Zeegers, Maurice P.
    Emes, Richard D.
    Abraham, Roby
    Raveendran, Vythilingam
    Boggild, Mike
    Gilford, Janice
    Hawkins, Clive P.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (09) : 1109 - 1116
  • [30] Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis
    Weatherby, SJM
    Mann, CLA
    Davies, MB
    Carthy, D
    Fryer, AA
    Boggild, MD
    Young, C
    Strange, RC
    Ollier, W
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2000, 6 (01): : 32 - 36
12345